159 related articles for article (PubMed ID: 37519823)
1. Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study.
Fu G; Li X; Guo F; Ruan X; Zhang W; Zhang W; Zhang Y; Chen Y; Li C; Chen J; Zheng X; Wang Z; Gao M
Front Oncol; 2023; 13():1216394. PubMed ID: 37519823
[TBL] [Abstract][Full Text] [Related]
2. Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications.
Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
Clin Endocrinol (Oxf); 2022 Sep; 97(3):355-362. PubMed ID: 35192214
[TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
[No Abstract] [Full Text] [Related]
5. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
[TBL] [Abstract][Full Text] [Related]
6. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
[TBL] [Abstract][Full Text] [Related]
7. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
[No Abstract] [Full Text] [Related]
8. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
[TBL] [Abstract][Full Text] [Related]
10. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
11. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
[TBL] [Abstract][Full Text] [Related]
12. Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma.
Vlad M; Zosin I; Timar B; Lazar F; Vlad A; Timar R; Cornianu M
Indian J Surg; 2016 Aug; 78(4):309-14. PubMed ID: 27574350
[TBL] [Abstract][Full Text] [Related]
13. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H
J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
17. Distant metastasis in medullary thyroid carcinoma: Clinical outcomes and implications of T stage.
Shao Y; Li G; Wei T; Gong R; Li Z; Zhu J; Lei J
Clin Endocrinol (Oxf); 2022 Nov; 97(5):676-684. PubMed ID: 35261045
[TBL] [Abstract][Full Text] [Related]
18. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study.
Wu X; Li B; Zheng C
Technol Cancer Res Treat; 2022; 21():15330338221078435. PubMed ID: 35188853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
